CYRAMZA: payments to doctors
Payments that named CYRAMZA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $941K
- Providers
- 5,961
- Transactions
- 22,471
- Average per transaction
- $42
The per-transaction average — $42 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,961 providers the average total is $158, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Lilly USA, LLC | $834,082 | 88.7% |
| Eli Lilly | $68,640 | 7.3% |
| Eli Lilly Export S.A. Puerto Rico Branch | $37,914 | 4.0% |